Matthew Collin Consultant Haematologist Newcastle

Matthew Collin Consultant Haematologist Newcastle

Matthew Collin Consultant Haematologist Newcastle leads advanced care in bone marrow transplantation and rare blood disorders. He works at the Northern Centre for Cancer Care, delivering innovative treatment for patients across the region. His approach focuses on patient-centered care, research-driven innovation, and excellence in clinical practice.

Clinical Expertise in Bone Marrow Transplantation

Professor Matthew Collin provides expert care in bone marrow transplantation. He treats complex conditions including adult immunodeficiency and histiocytic disorders. His patients benefit from modern techniques that improve outcomes and recovery. Furthermore, he ensures that every treatment follows the latest research and clinical guidelines.

Matthew Collin Consultant Haematologist Newcastle in Research

Matthew Collin contributes significantly to medical research in haematology. His studies on human dendritic cell (DC) biology are internationally recognized. He led discoveries in the classification of human DCs and their role in graft versus host disease. His work also uncovered genetic DC deficiencies caused by GATA2 and IRF8 mutations. These breakthroughs originated in Newcastle and continue to influence global treatment approaches.

Academic and Professional Background

Professor Collin began his academic journey at Oxford University, earning a PhD in Immunology in 1992 and a Medical Degree in 1995. He completed specialist training in haematology and transplantation in the Northern Region by 2004. By 2006, he became a Consultant Haematologist. In 2010, he advanced to Professor of Haematology and Director of Bone Marrow Transplantation. His leadership ensures that the Northern Centre for Cancer Care delivers outstanding service and research integration.

Dedication to Patient-Centered Care

Patients trust Matthew Collin for his combination of clinical excellence and compassionate care. He focuses on providing modern, evidence-based treatments that enhance quality of life. Through close collaboration with a multidisciplinary team, he ensures personalized solutions for each patient. His mission remains clear: advance medical research while delivering the highest standards of care.